Cerebral collateral circulation in experimental ischemic stroke by unknown
Cuccione et al. Exp & Trans Stroke Med  (2016) 8:2 
DOI 10.1186/s13231-016-0015-0
REVIEW
Cerebral collateral circulation 
in experimental ischemic stroke
Elisa Cuccione1,2, Giada Padovano1, Alessandro Versace1, Carlo Ferrarese1,3 and Simone Beretta1,3*
Abstract 
Cerebral collateral circulation is a subsidiary vascular network, which is dynamically recruited after arterial occlu-
sion, and represents a powerful determinant of ischemic stroke outcome. Although several methods may be used 
for assessing cerebral collaterals in the acute phase of ischemic stroke in humans and rodents, they are generally 
underutilized. Experimental stroke models may play a unique role in understanding the adaptive response of cerebral 
collaterals during ischemia and their potential for therapeutic modulation. The systematic assessment of collateral 
perfusion in experimental stroke models may be used as a “stratification factor” in multiple regression analysis of 
neuroprotection studies, in order to control the within-group variability. Exploring the modulatory mechanisms of cer-
ebral collaterals in stroke models may promote the translational development of therapeutic strategies for increasing 
collateral flow and directly compare them in term of efficacy, safety and feasibility. Collateral therapeutics may have a 
role in the hyperacute (even pre-hospital) phase of ischemic stroke, prior to recanalization therapies.
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Background
Cerebral collateral circulation is a subsidiary vascular net-
work which is dynamically recruited after arterial occlu-
sion and may provide residual blood flow to ischemic 
areas. Cerebral collateral flow during acute ischemic 
stroke is highly variable among different individuals and 
is emerging as a strong prognostic factor either in unse-
lected stroke patients and in patients treated with intra-
venous rtPA or endovascular recanalization therapy [1]. 
Experimental stroke models could play a crucial role for 
a deeper understanding of the adaptive and modulatory 
mechanisms of cerebral collateral circulation. This may 
promote the translational development of a new stroke 
therapy, based on the therapeutic modulation of collat-
eral flow in the hyperacute phase of ischemic stroke prior 
to recanalization therapies [2].
Here, we review the current methods for assessing cer-
ebral collaterals during acute ischemic stroke and the 
most promising collateral therapeutic strategies, focusing 
on experimental stroke models.
Cerebral collateral circulation in humans 
and rodents
Many similarities, with some notable differences, exist 
between humans and rodents in term of cerebral col-
lateral circulation. The circle of Willis includes the ante-
rior communicating artery in humans, while this vessel 
is totally absent in rodents, whose proximal segments of 
anterior cerebral arteries (ACA) converge to form one 
single median artery called Azigos ACA. In case of occlu-
sion of cervical arteries, the circle of Willis represents a 
compensatory system to rapidly redistributing blood flow 
in both species. In rodents, the pterygopalatine artery 
originates from the proximal internal carotid artery 
(ICA) and provide extracranial collateral connections 
between external carotid artery and ICA via many arte-
rial branches to facial, orbital and meningeal districts. In 
both humans and rodents, each cerebral artery provides 
blood flow to its vascular territory ramifying along the 
cortical surface to form a pial arteriolar network, creat-
ing anastomotic connections among different vascular 
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territories, known as leptomeningeal anastomoses 
(LMAs). LMAs are mostly developed between cortical 
branches of middle cerebral artery (MCA) and ACA or 
posterior cerebral artery. In case of proximal occlusion of 
a cerebral artery, dynamic blood flow diversion through 
these anastomoses may provide residual (retrograde) 
blood flow to the cortical surface of the occluded artery 
territory, distally from the occlusion.
Assessment of cerebral collateral flow in acute 
stroke patients
The anatomy of cerebral collaterals in acute stroke 
patients can be assessed using conventional digital sub-
traction angiography (DSA), CT angiography (CTA) or 
MR angiography (MRA), while their functional perfor-
mance can be studied through tissue perfusion evalu-
ation, via CT and MR perfusion techniques (PCT and 
PWI). At present, there is no agreement in clinical prac-
tice on which imaging should be performed, when after 
stroke and which patients would benefit most from cer-
ebral collateral imaging. DSA is the gold standard for 
evaluating the recruitment of cerebral collaterals, but 
it is invasive and usually reserved for patients selected 
for endovascular procedures. CTA is able to provide 
direct visualization of collateral flow after arterial occlu-
sion (Fig. 1) [3]. However, if imaging acquisition is done 
before the contrast arrives in the leptomeningeal vessels, 
there is a risk to underestimate the real extent of collat-
erals. Recently, multiphase CTA techniques have been 
developed to address this issue [4]. PCT allows to study 
the performance of collateral flow, which is indicated by 
preserved or increased cerebral blood volume (CBF) and 
augmented mean transit time [5]. Multimodal MRI pro-
vides a number of tools to assess collateral flow, although 
with some limitations. MRA can determine alterations 
of cerebral circulation within large cerebral arteries, 
with less spatial resolution compared to CTA [6]. FLAIR 
images on MR are able to show vascular hyperintensi-
ties distal to an occluded cerebral artery, due to the pres-
ence of a slow, retrograde blood flow in collateral vessels 
[7]. PWI could assess the performance of collateral flow, 
showing cerebral tissue with relatively preserved CBF 
and prolonged blood transit time [8]. Arterial spin-label-
ling MRI can detect brain regional hypoperfusion [9] and 
potentially identify the presence of leptomeningeal col-
lateral routes [10].
Fig. 1 Clinical imaging of cerebral collaterals during acute ischemic stroke using CT-angiography. Collateral vessels [(A) small arrows] are visible in 
the right hemisphere. These vessels have been recruited after acute right MCA occlusion [(a) large arrows]. This patient was treated with intravenous 
thrombolysis and developed a small subcortical lesion (B), while the entire cortical territory was intact (C)
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Assessment of cerebral collateral flow 
in experimental stroke models
In experimental stroke models, both the site and the 
duration of arterial occlusion are controlled. Continuous 
or repeated assessment of cerebral collateral flow could 
be performed, including pre-stroke assessment. For these 
reasons, preclinical research could play a crucial role for 
a deeper understanding of collateral response during 
cerebral ischemia and promote the translational devel-
opment of collateral-based therapies. However, both cer-
ebrovascular differences between different species and 
strains and inter-individual variability need to be meticu-
lously considered to achieve effective results in this field 
[11].
Although some techniques used in stroke patients, 
such as DSA or MRI, could be used in stroke models for 
assessing cerebral collateral flow [12–14], significant lim-
itations including costs, logistics and low spatial resolu-
tion prevent their widespread use. An easier assessment 
of collateral blood flow with great spatial and temporal 
resolution can be achieved using optical imaging and 
perfusion monitoring in experimental stroke models [15].
Laser speckle contrast imaging (LSCI) [16] provides 
maps of cortical blood flow, derived from the blurring 
of the speckle contrast pattern of a coherent light (laser), 
which is scattered by the motion of red blood cells (RBC) 
when directed to the cortical surface. Full-field imaging 
of the cortical surface and nearly real-time information 
about blood flow in both surface vessels and parenchyma 
are obtained. A cranial window is usually performed, 
although acquisition through intact skull is theoreti-
cally possible in mice. LSCI was used in rodent models 
of MCA occlusion (MCAO) to study changes in regional 
cerebral blood flow (CBF) and the dynamic response 
of LMAs to the vascular occlusion. After thromboem-
bolic MCAO, blood flow establishment through pial 
arteriolar anastomoses was immediately evident, sug-
gesting a prompt pathophysiological recruitment of the 
collateral circulation, also persisting after 24  h [17]. In 
another study [18], LMAs immediately provided blood 
flow after permanent MCAO and were classified in per-
sistent, impermanent and transient on the basis of their 
dynamic changes. Though the speckle contrast values are 
indicative of RBC motion, they are not directly related to 
their speed or flow, with the exact relationship still unde-
fined [19]. For this reason, LSCI can be used to measure 
relative blood flow changes, rather than for its absolute 
quantification [20].
In contrast to LSCI, two photon laser scanning micros-
copy (TPLSM) is an optical technique providing quan-
titative measure of blood flow velocity and direction in 
single vessels, with depth resolution up to 1 mm. Single 
arterioles, venules and capillaries of both surface and 
subsurface vasculature are resolved after intravenous 
injection of dextran conjugated with a fluorescent dye. 
A cranial window is required and scanning procedure 
is time-consuming. Collateral response after occlusion 
of both pial and penetrating arterioles in rats [21] were 
studies using TPLSM.
Laser-Doppler flowmetry (LDF) is a well-established 
technique for tissue perfusion monitoring and is recom-
mended to confirm successful occlusion and exclude sub-
arachnoid hemorrhage in experimental ischemic stroke 
[22]. Optical probes can be located on the cerebral cortex 
or skull, providing an integrated reading of the underly-
ing pial vasculature and parenchymal capillary bed in 
1 mm3 volume. Real-time relative cortical CBF values are 
obtained, while absolute CBF quantification cannot be 
achieved [23]. Our group developed an optimized system 
for multi-site LDF monitoring in rats during transient 
MCAO [24]. A custom made holder for two probes was 
attached to the intact skull to allow continuous monitor-
ing of cerebral perfusion in the central MCA territory 
(Probe 1) and in the borderzone between ACA and MCA 
territories (Probe 2) (Fig.  2a). Although not providing a 
direct imaging of the LMAs, multi-site LDF monitor-
ing allows real-time assessment of cerebral perfusion in 
two hemodynamically distinct territories during MCAO 
(Fig. 2b). Perfusion deficit recorded by Probe 2 is consid-
ered an index of the functional performance of LMAs, 
while perfusion deficit recorded by Probe 1 is used to 
confirm occlusion and reperfusion. Multi-site LDF may 
represent an easy method to quantify the functional acti-
vation of LMAs during ischemia in experimental stroke 
models and assess the effect of treatments.
The use of any of these methods (or a combination of 
them) to monitor arterial occlusion and collateral perfu-
sion cannot be over emphasized to improve accuracy of 
pre-clinical stroke research. Advantages and drawbacks, 
in terms of temporal and spatial resolution, invasiveness 
and affordability of each technique are shown in Table 1.
Cerebral collateral flow as stratification factor 
in neuroprotection studies
Despite over 1000 putative neuroprotective agents 
obtained promising results in experimental stroke mod-
els [25], no successful translation has occurred in the 
phase-3 stroke clinical trials performed so far [26]. Poor 
methodology of preclinical studies, including study 
design, heterogeneity of stroke models and stroke sever-
ity, time window, drug targeting, effective dose-finding 
and outcome assessment has been advocated as one of 
the main reasons of this failure in translation [27–29].
A well-recognized limitation of preclinical stroke 
models is outcome variability [11], particularly regard-
ing infarct size [30] which is the most commonly used 
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primary outcome. In a recent meta-analysis of 502 con-
trol groups in preclinical stroke experiments, the aver-
age infarct size coefficient of variation was about 30  % 
(ranging from 1.7 to 148 %) [31]. The problem with high 
outcome variability is that a higher number of animals 
is needed to get an adequate statistical power, which is 
problematic from both an ethical and economical point 
of view. The main reasons of infarct size variability in 
stroke modes are not completely understood. Although 
rat strain, surgical procedures, occluding filaments, 
anaesthesia and physiological monitoring have been 
demonstrated to be associated with infarct size variabil-
ity [22, 32], factors related to inter-individual differences 
in cerebrovascular anatomy [33] and cerebral collateral 
circulation [34] have been reported. Interestingly, the 
National Centre for the Replacement, Refinement and 
Reduction of Animals in Research (NC3Rs) is currently 
funding a project (2014–2015) entitled “Determining the 
source of variability within experimental stroke models”, 
which is mostly focused on vascular anatomy and reper-
fusion [35].
The variability of cerebral hemodynamics dur-
ing ischemia has been largely neglected in preclinical 
research, as well as the influence of drugs on CBF [36]. 
Monitoring CBF, including cerebral collateral flow, may 
help to detect indirect neuroprotective effects in pre-
clinical studies and predict outcome variability between 
treatment groups. Similarly to humans, the functional 
performance of collateral circulation during cerebral 
ischemia displays inter-individual variability in rodents 
[37]. Our group showed that the functional performance 
of the cerebral collaterals during MCAO in rats, assessed 
using multi-site LDF monitoring, predicted infarct size 
and functional outcome more accurately than conven-
tional perfusion deficit in the ischemic core [34]. Further 
experiments using the same method, in a series of 45 
untreated animals, confirmed a highly significant correla-
tion of collateral flow during MCAO and stroke outcome 
(Fig. 3; unpublished results).
Animal stratification by collateral flow during MCAO 
represents a promising tool to adjust for outcome vari-
ability in experimental stroke studies. Using cerebral 
collateral flow during MCAO as a covariate in multiple 
regression analysis may represent a simple method to 
stratify animals in term of pre-treatment perfusion defi-
cit, reducing the within group variability and improv-
ing efficacy analysis in preclinical neuroprotection 
studies. Further studies are needed to determine the 
Fig. 2 Monitoring of cerebral collateral flow in experimental 
ischemic stroke using multi-site Laser Doppler flowmetry. a The 
positions of the Laser Doppler probes are shown, with reference to 
their underlying MCA territory (white dotted line) and bregma. Probe 
1 = central MCA territory (ischemic core; −1 mm from bregma, 5 mm 
from midline); Probe 2 = MCA–ACA borderzone territory (collateral 
flow; +2 mm from bregma, 2 mm from midline). b Laser Doppler 
tracings are shown from a representative animal showing a larger 
perfusion deficit in Probe 1 compared to Probe 2 during MCAO, 
suggesting functionally active intracranial collaterals under ischemic 
conditions. P.U. perfusion units
Table 1 Methods for the assessment of collateral blood flow in experimental stroke models
Method Temporal resolution Spatial resolution CBF information Invasiveness Cost
MRI Not real-time Whole brain with low  
resolution
Perfusion maps None High
LSCI Almost real-time Strictly surface reading Relative CBF values Craniotomy may  
be necessary
Moderate
TPLSM Repetitive scanning required Depth resolution Quantitive CBF velocity and 
direction in single vessels
Craniotomy necessary High
LDF (multi-site) Real-time monitoring Integrated reading in 1 mm3 
cortical volume
Relative CBF values Craniotomy not necessary Moderate
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more suitable method, timing and statistical tool for col-
lateral flow assessment in pre-clinical neuroprotection 
trials.
Acute therapeutic modulation of cerebral collateral 
flow
Intravenous thrombolysis with rtPA (Alteplase) within 
4.5  h from symptom onset (for any vessel occlusion) 
and endovascular thrombectomy within 6 h from symp-
tom onset (for large vessel occlusion) are currently the 
best therapeutic options for acute ischemic stroke [38, 
39]. Unfortunately, recanalization is not always success-
ful and, even when achieved, may be futile because of 
delayed reperfusion, hemorrhagic transformation, re-
occlusion or vascular collapse downstream [40, 41]. Vas-
cular aspects beyond the occlusion are often neglected 
[42]. Nonetheless, modulating collateral blood flow in 
order to augment or maintain perfusion to the ischemic 
penumbra could represent a new therapeutic strategy 
for the hyperacute (even pre-hospital) phase [2], particu-
larly if applied before recanalization or neuroprotective 
therapies. Although different strategies (summarized in 
Table  2) could be used to modulate cerebral collateral 
flow during acute ischemic stroke, extensive research 
is needed in both animal models and stroke patients to 
establish the best approach in term of benefit-to-risk 
ratio.
Increasing systemic blood pressure represents a first 
strategy. Phenylephrine, a selective α1-adrenergic recep-
tor agonist, causes systemic vasoconstriction with very 
limited effects on cerebral vessels. A 30  % augmenta-
tion of blood pressure obtained through phenylephrine 
infusion after distal MCAO induction in mice enhanced 
cortical CBF both in core and penumbra [43]. In small 
clinical studies, norepinephrine- o phenylephrine-
induced hypertension improved outcome in stroke 
patients [44, 45], but collateral circulation was not 
directly assessed, leaving its contribution unclear.
Increasing intravascular volume may represents a sec-
ond strategy. Cerebral blood volume augmentation by 
plasma expansion and haemodiluition could improve 
cerebral perfusion in experimental stroke models [46]. 
However, in acute stroke trials performed in the 1990s, 
plasma expansion by dextran 40 and hydroxyethyl starch 
showed no benefit on neurological outcome or mor-
tality [47]. Notably, all these early clinical studies were 
performed in the pre-thrombolysis era and outside a 
meaningful therapeutic window (patients were enrolled 
many hours or even days after symptom onset) and 
cerebral collateral flow was not assessed. Intravenous 
albumin administration has been reported to enhance 
cerebral perfusion and provide neuroprotection in pre-
clinical works [48, 49]. However, a large randomized 
clinical trial showed no clinical benefit of intravenous 
albumin solution 25 % in ischemic stroke patients com-
pared to standard treatment [50]. Notably, 85 % of these 
patients were treated with rtPA and intravenous albumin 
was administered on average 60  min after (not before) 
recanalization therapy.
Induction of selective cerebral vasodilation is a third 
strategy. Nitric oxide (NO) is a strong endogenous vas-
odilator with therapeutic potential for ischemic stroke 
[51]. NO inhalation following MCAO in adult mice 
induced a selective arteriolar vasodilation within the 
ischemic penumbra, likely through collateral arterioles, 
leading to decreased brain damage and improved func-
tional outcome [52]. No results are available for inhaled 
nitric oxide in acute stroke patients. Sphenopalatine 
ganglion (SPG) electrostimulation activates parasympa-
thetic fibers innervating intracranial vessels leading to 
their vasodilation. In preclinical studies, SPG-stimulation 
started after MCAO preserved DWI–PWI mismatch 
and reduced infarct size [53]. SPG electrostimulation in 
ischemic stroke patients has been demonstrated to be 
safe [54]. Stimulating cerebral function during ischemia 
could non-invasively enhance collateral perfusion of 
affected regions through neurovascular coupling mecha-
nisms (i.e., functional hyperaemia) [55]. Sensory cortical 
activation induced by whiskers stimulation in rats lead to 
a gradual reperfusion via MCA distal collaterals, when 
the treatment was initiated within a critical time window 
from MCAO onset [56]. No results are available for sen-
sory stimulation in acute stroke patients.
Fig. 3 Relationship between cerebral collateral flow during MCAO 
and stroke outcome in rats. Linear regression between infarct volume 
and perfusion deficit during MCAO in the territory of leptomeningeal 
collaterals, measured using multi-site laser Doppler, was calculated 
for 45 consecutive untreated rats (p < 0.0001; Pearson’s r = −0.59). 
Notably, the correlation between infarct volume and perfusion 
deficit in the ischemic core (central MCA territory) was not significant 
(p = 0.14, smaller graph)
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Selective cerebral arteriolar vasodilation could be 
obtained using acetazolamide, which inhibits carbonic 
anhydrase and consequently augments CO2 levels, caus-
ing pial arteriolar vasodilation and increased cortical per-
fusion in piglets [57]. In clinical practice, acetazolamide 
is used to test hemispheric cerebrovascular reactivity in 
patients with chronic cerebrovascular occlusions [58]. 
Quite surprisingly, the only report of acetazolamide in 
experimental stroke dates back to 1971 [59], was per-
formed in cats undergoing permanent MCAO (without 
reperfusion) and the drug was administered using a very 
late time window (48–54 h after the onset ischemia). No 
results are available for acetazolamide in acute stroke 
patients.
Cerebral flow diversion is a fourth strategy. Gravita-
tional influences of head positioning after acute vascular 
occlusion may affect pressure gradients in cerebral circu-
lation, which enhancement may promote leptomeningeal 
recruitment. Augmentation of cerebral perfusion and 
increased MCA blood flow velocity has been reported 
in stroke patients after flat head positioning [60, 61] and 
after 5° head-down tilt following bilateral CCAO in mice 
[62]. A temporary partial occlusion of the abdominal 
aorta may divert flow from the splanchnic circulation. 
Transient aortic occlusion increased blood flow through 
ACA–MCA LMAs after thromboembolic MCAO in rats, 
restoring it to baseline levels and maintaining stroke-
induced vasodilation [63]. A randomized clinical trial of 
this procedure in acute ischemic stroke patients demon-
strated an acceptable safety profile and suggested efficacy 
in post hoc subgroup analysis [64].
Conclusions
A limited number of clinical and preclinical stroke stud-
ies focused on cerebral collateral circulation. Generally, 
neuroprotective effects are being sought, whereas the 
contribution of collateral blood flow is rarely considered 
or just inferred. Preclinical stroke research has the poten-
tial to directly study the adaptive capacity and modula-
tory mechanisms of cerebral collateral flow during focal 
cerebral ischemia, using different methods and in differ-
ent experimental conditions. These preclinical efforts are 
likely to be worthwhile and may produce useful transla-
tional concepts and direct comparisons of the different 
strategies to enhance cerebral collateral flow, including 
some therapeutic approaches which did not prove suc-
cessful in past clinical trials conducted in the pre-throm-
bolysis era.
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